Analyzing the UALCAN public database indicated that the FOXD3 gene was differentially expressed in various tumor tissues (Fig. 1A) and its relative expression level in colon cancer (n = 286) tissues was lower than that in the normal tissues (n = 41) (Fig. 1B). This evidence concerns the gene FOXD3 and colonic neoplasm.